Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on estrogen signaling.

Zhang Weihua1, Sandra Andersson, Guojun Cheng

  • 1Department of Medical Nutrition, Department of Biosciences, Karolinska Institute, NOVUM, S-141 86 Huddinge, Sweden.

FEBS Letters
|June 28, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preoperative Anxiety Levels and Postoperative Opioid Use in Patients Undergoing Arthroscopic Rotator Cuff Repair: A Prospective Cohort Study.

Orthopaedic journal of sports medicine·2026
Same author

The Limited Evidence Base for Multilevel Lumbar Interbody Fusion and Its Consequences for Clinical Conclusions: A Systematic Review.

Journal of clinical medicine·2026
Same author

Complication, revision, and readmission rates following reverse total shoulder arthroplasty in wheelchair-dependent patients.

Journal of shoulder and elbow arthroplasty·2026
Same author

Controllable Synthesis and Formation Mechanism of Spherical MgCO<sub>3</sub> Prepared Using MgCl<sub>2</sub>·6H<sub>2</sub>O and Urea via a Deep Eutectic Solvent Method.

Inorganic chemistry·2026
Same author

Body Mass Index as a Risk Factor for Readmission Rates in Direct Anterior Approach Total Hip Arthroplasty.

Arthroplasty today·2025
Same author

No Clinically Significant Differences in Patient-Reported Outcomes and Range of Motion Between Early and Delayed Mobilization After Primary Distal Biceps Tendon Repair: A Systematic Review and Meta-analysis.

The American journal of sports medicine·2025
Same journal

Identification of a Shiga toxin A-derived peptide internalized into Gb3 receptor-bearing cells via interaction with the Shiga toxin B subunit.

FEBS letters·2026
Same journal

The dual role of lectins in cancer-immunotherapy tools and therapeutic targets.

FEBS letters·2026
Same journal

Decoding the dynamic extracellular matrix in cancer-3D models and bioscaffolds rewire the rules of tumor progression.

FEBS letters·2026
Same journal

Extending the classical sequence-structure-function paradigm through protein dynamics and context-dependent behavior.

FEBS letters·2026
Same journal

α-Synuclein aggregation landscape from phase separation to neurotoxic intermediates.

FEBS letters·2026
Same journal

Modelling stem cell differentiation related processes-A practical overview for biologists.

FEBS letters·2026
See all related articles

The discovery of estrogen receptor beta (ERbeta) shifted our understanding of estrogen signaling. ERbeta plays key roles in various tissues and offers pharmaceutical potential for cancer treatment.

Area of Science:

  • Endocrinology and Molecular Biology
  • Reproductive Biology
  • Cancer Research

Background:

  • The discovery of estrogen receptor beta (ERbeta) in 1995 revolutionized the understanding of estrogen signaling.
  • Estrogen receptor beta (ERbeta) often antagonizes estrogen receptor alpha (ERalpha) but also uniquely regulates specific genes.

Discussion:

  • ERbeta knockout mouse studies reveal its critical functions in the ovary, central nervous system, mammary and prostate glands, hematopoiesis, immune system, vasculature, and bone.
  • The distinct roles of ERbeta highlight its significance beyond traditional estrogen signaling pathways.

Key Insights:

  • Estrogen receptor beta (ERbeta) exhibits diverse physiological roles across multiple organ systems.
  • ERbeta's unique functions present new avenues for targeted therapeutic strategies.

Related Experiment Videos

Outlook:

  • ERbeta-specific ligands are emerging as promising pharmaceutical agents, particularly for treating various forms of cancer.
  • Further research into ERbeta signaling pathways could unlock novel therapeutic applications in endocrinology and beyond.